NeoStrata HQ Plus Lightening Gel
Texto original en francés.
Producto de salud natural autorizado en Canadá
El análisis de dosis orales no se aplica sin una vía exclusivamente oral establecida.
Composición
| Ingrediente medicinal y fuente | Por unidad posológica, según la fuente |
|---|---|
| Hydroquinone | 4 % (p/p) |
Ingredientes no medicinales
Ammonia Solution, Strong NF, Chlorure de benzalkonium, Ethoxydiglycol, Eau, Hydroxyethyl Cellulose, Métabisulfite de sodium, Éthanol, Gluconolactone, Acide glycolique, propylèneglycol
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
| Adultes | minimum : 20 ans | Non précisée | minimum : 1 Tous les jours ; maximum : 2 Tous les jours |
Usos autorizados en Canadá
Lightens age spots and hyperpigmentation.
Texto original en francés.
Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Précautions et mises en garde : To be used on the advice of a physician. For external use only. Use only as directed. Do not apply over sunburn or irritated skin. Do not apply over sunburn or irritated skin. Avoid contact with eyes, mucous membranes and broken or irritated skin. In case of contact, rinse thoroughly with water. Test for sensitivity. Apply only to small skin surface area. Discontinue use and consult a physician in case of skin reactions or a blue-black darkening of the skin. A mild transient stinging or minor redness may occur in people with sensitive skin. To test for sensitivity, before treatment, apply to area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritations occurs within 24 hours, begin treatment for up to 12 weeks. Discontinue use in case of irritation, rash, excessive inflammatory response or if a gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but when there is an excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. This product contains glycolic acid, an alpha-hydroxy acid (AHA), which may increase skin's sensitivity to the sun and particularly the possibility of sunburn. Limit sun exposure and apply a sunburn protectant while using this product and for a week afterwards. The safety of topical hydroquinone use during pregnancy or for children 12 years or less has not been established. Do not use this product if you have used it or any of its ingredients before and skin sensitivity or irritation has occurred. Do not use this product if you are nursing, pregnant or if you intended to become pregnant within 3 months of use. If you have a family history or, have or have had or are at risk of developing cancer, do not use. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of the insert before prescribing or dispensing this product. Close patient supervision is recommended. A bitter taste and anesthetic effect may occur if applied to the lips. Sunscreen use is essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Treatment should be limited to relatively small areas of the body at one time. Keep out of reach of children. Not for use on children under 12 years of age. In case of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately. Note: Slight darkening of the product is normal when exposed to air and does not affect its potency. When this happens, extract a tiny amount of product, clean with a cotton swab and discard prior to use. If the entire content becomes brown, discontinue use and consult a physician. Store at room temperature.
Texto original en francés.
Ficha del producto
- Titular
- Opella Canada Inc.
- NPN o DIN-HM
- 02245719
- Estado
- Licencia no activa
- Fecha de licencia
- 17 de diciembre de 2007
- Fecha de revisión
- 21 de febrero de 2014
- Forma
- Gel
- Vía de administración
- Topique
- Tipo de solicitud
- DIN de transition
Fuente
Ficha oficial de Health Canada, licencia 02245719
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Texto original en inglés.
Texto original en francés.
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Lista en la revisión oficial del (registro: Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias).
¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.